Adverum Biotechnologies, Inc. (59) | Human Resources (38)

Browse by Subcategory

Recent Contracts

Employment Agreement (Filed With SEC on March 29, 2022)
Form of Change in Control (Filed With SEC on March 29, 2022)
Form of Performance Stock Unit Award Grant Notice and Performance Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan (Filed With SEC on March 29, 2022)
Consulting Agreement between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)
Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)
Non-Employee Director Compensation Policy, effective May 5, 2021 (Filed With SEC on May 6, 2021)
Employment Agreement (Filed With SEC on March 29, 2022)
Employment Agreement between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of November 12, 2021 (Filed With SEC on March 29, 2022)
Employment Agreement between Adverum Biotechnologies, Inc. and Brigit Riley, dated as of May 21, 2021 (Filed With SEC on March 29, 2022)
Employment Offer Letter with Julie Clark, dated April 2, 2020 (Filed With SEC on August 5, 2021)
Consulting Agreement between Adverum Biotechnologies, Inc. and Leone Patterson, dated June 24, 2021 (Filed With SEC on August 5, 2021)
Change in Control and Severance Agreement with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)
Change in Control and Severance Agreement with Julie Clark, dated May 25, 2021 (Filed With SEC on August 5, 2021)
Employment Offer Letter with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)
Consulting Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated March 18, 2021 (Filed With SEC on May 6, 2021)
Non-Employee Director Compensation Policy, effective March 31, 2021 (Filed With SEC on May 6, 2021)
Consulting Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)
Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)
Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021 (Filed With SEC on May 6, 2021)
Adverum Biotechnologies, Inc. Amended and Restated 2006 Equity Incentive Plan (Filed With SEC on August 10, 2020)
Amended and Restated Non-Employee Director Compensation Policy, effective June 22, 2020 (Filed With SEC on August 10, 2020)
Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated (Filed With SEC on August 10, 2020)
Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated (Filed With SEC on August 10, 2020)
Change in Control and Severance Agreement Laurent Fischer, dated (Filed With SEC on August 10, 2020)
Employment Offer Letter with Laurent Fischer, dated (Filed With SEC on August 10, 2020)
Adverum Biotechnologies, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 10, 2020)
Employment Agreement, dated (Filed With SEC on May 28, 2020)
Non-Employee Director Compensation Policy, effective December 13, 2019 (Filed With SEC on March 12, 2020)
Employment Agreement, dated October 11, 2019, among Adverum Biotechnologies, Inc. and Peter Soparkar (Filed With SEC on November 7, 2019)
Employment Agreement, dated February 28, 2019, among Adverum Biotechnologies, Inc. and Aaron Osborne (Filed With SEC on November 7, 2019)
Non-Employee Director Compensation Policy, effective August 15, 2019 (Filed With SEC on November 7, 2019)
Separation Letter and Consulting Agreement, dated September 3, 2019 and September 6, 2019, respectively, between Adverum Biotechnologies, Inc. and Jennifer Cheng (Filed With SEC on November 7, 2019)
Separation and Consulting Agreement, dated July 31, 2019, between Adverum Biotechnologies, Inc. and Mehdi Gasmi (Filed With SEC on November 7, 2019)
Separation Letter, dated May 1, 2019, between Adverum Biotechnologies, Inc. and Paul Cleveland (Filed With SEC on August 8, 2019)
Employment Agreement, dated February 27, 2019, with Thomas Leung (Filed With SEC on May 8, 2019)
Change in Control and Severance Agreement with Leone Patterson, dated October 24, 2018 (Filed With SEC on March 6, 2019)
Adverum Biotechnologies, Inc. 2014 Equity Incentive Award Plan, as amended and restated (Filed With SEC on March 6, 2019)
Amendment to the Change in Control and Severance Agreement for Mehdi Gasmi (Filed With SEC on March 6, 2019)